• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prevention and control of hypertension in New Zealand: a reappraisal.

作者信息

Beaglehole R, Bonita R, Jackson R, Stewart A

机构信息

Department of Community Health, University of Auckland, School of Medicine.

出版信息

N Z Med J. 1988 Jul 27;101(850):480-3.

PMID:3134626
Abstract

A new national policy for the prevention and control of hypertension is required in New Zealand. The first priority is the prevention of hypertension with the development of a population strategy directed at encouraging healthy nutritional and exercise habits. Pharmacological management or specific nonpharmacological treatment of individuals is the second priority and decisions about treatment levels have important logistic and cost implications. Given the limited absolute benefits of treatment to individuals, the current policy of initiating treatment at a diastolic blood pressure of greater than or equal to 95 mmHg should be revised upwards. A population approach to the prevention of hypertension is essential in New Zealand because the majority (57%) of excess deaths due to raised blood pressure occur in people with diastolic blood pressure in the range 80-94 mmHg. A fall in the population mean diastolic blood pressure of 2 mmHg would have the same effect on total mortality rates as the successful treatment of everyone with a diastolic blood pressure greater than or equal to 100 mmHg. A national multidisciplinary group should be established to formulate strategies for preventing hypertension in New Zealand and to review current treatment guidelines.

摘要

相似文献

1
Prevention and control of hypertension in New Zealand: a reappraisal.
N Z Med J. 1988 Jul 27;101(850):480-3.
2
Diet, serum cholesterol and the prevention of coronary heart disease in New Zealand.饮食、血清胆固醇与新西兰冠心病的预防
N Z Med J. 1988 Jun 22;101(848):415-8.
3
Lack of control of high blood pressure and treatment recommendations in Canada.加拿大高血压控制不力及治疗建议
Can J Cardiol. 2002 Jun;18(6):657-61.
4
[Clinical guidelines for detection, prevention, diagnosis and treatment of systemic arterial hypertension in Mexico (2008)].[墨西哥系统性动脉高血压的检测、预防、诊断及治疗临床指南(2008年)]
Arch Cardiol Mex. 2008 Apr-Jun;78 Suppl 2:S2-5-57.
5
Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level.南非高血压指南的成本效益分析:绝对风险与血压水平
Circulation. 2005 Dec 6;112(23):3569-76. doi: 10.1161/CIRCULATIONAHA.105.535922.
6
Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.预防和控制高血压的生活方式改变。1. 方法及加拿大建议概述。加拿大高血压协会、加拿大高血压预防与控制联盟、加拿大卫生部疾病控制实验室中心、加拿大心脏与中风基金会。
CMAJ. 1999 May 4;160(9 Suppl):S1-6.
7
Blood pressure prevalences and levels for a multicultural population in Auckland, New Zealand: results from the Diabetes, Heart and Health Survey 2002/2003.新西兰奥克兰多元文化人群的血压患病率及水平:2002/2003年糖尿病、心脏与健康调查结果
N Z Med J. 2006 Nov 17;119(1245):U2318.
8
Blood pressure levels and the treatment of hypertension in Auckland, 1982.1982年奥克兰的血压水平与高血压治疗情况
N Z Med J. 1983 Oct 12;96(741):751-4.
9
ESH-ESC guidelines for the management of hypertension.欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)高血压管理指南
Herz. 2006 Jun;31(4):331-8. doi: 10.1007/s00059-006-2829-3.
10
Improvement in hypertension management in England: results from the Health Survey for England 2003.英格兰高血压管理的改善:2003年英格兰健康调查结果
J Hypertens. 2006 Jun;24(6):1187-92. doi: 10.1097/01.hjh.0000226210.95936.bc.

引用本文的文献

1
Economic factors in the initiation of antihypertensive therapy.启动抗高血压治疗的经济因素。
Pharmacoeconomics. 1992 Oct;2(4):324-34. doi: 10.2165/00019053-199202040-00007.
2
Economic constraints and prescribing patterns in New Zealand.
Pharmacoeconomics. 1992 Sep;2(3):189-97. doi: 10.2165/00019053-199202030-00002.